{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:21:33Z","timestamp":1790623293199,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008102","name":"University of Cincinnati","doi-asserted-by":"publisher","award":["UG1DA049444"],"award-info":[{"award-number":["UG1DA049444"]}],"id":[{"id":"10.13039\/100008102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008102","name":"University of Cincinnati","doi-asserted-by":"publisher","award":["UG1DA015831"],"award-info":[{"award-number":["UG1DA015831"]}],"id":[{"id":"10.13039\/100008102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015615","name":"National Institute on Drug Abuse Treatment Clinical Trials Network","doi-asserted-by":"publisher","award":["UG1DA049444"],"award-info":[{"award-number":["UG1DA049444"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015615","name":"National Institute on Drug Abuse Treatment Clinical Trials Network","doi-asserted-by":"publisher","award":["UG1DA013732"],"award-info":[{"award-number":["UG1DA013732"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011218","name":"Sandoz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.josat.2023.209030","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T02:19:21Z","timestamp":1680574761000},"page":"209030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study"],"prefix":"10.1016","volume":"149","author":[{"given":"Frankie B.","family":"Kropp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela C.","family":"Smid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Lofwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha M.","family":"Wachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Wilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. John","family":"Winhusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209030_bb0005","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee opinion no. 711. Opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstetrics & Gynecology"},{"issue":"2S Supplement 1","key":"10.1016\/j.josat.2023.209030_bb0015","first-page":"1","article-title":"The ASAM National Practice Guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209030_bb0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13722-018-0126-0","article-title":"Frequency and associated risk factors of non-fatal overdose reported by pregnant women with opioid use disorder","volume":"13","author":"Bagley","year":"2018","journal-title":"Addiction Science & Clinical Practice"},{"issue":"4","key":"10.1016\/j.josat.2023.209030_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2020.100225","article-title":"Barriers to accessing opioid agonist therapy in pregnancy","volume":"2","author":"Bedrick","year":"2020","journal-title":"American Journal of Obstetrics & Gynecology MFM"},{"issue":"4","key":"10.1016\/j.josat.2023.209030_bb0030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.acap.2016.10.003","article-title":"Wide variation found in care of opioid-exposed newborns","volume":"17","author":"Bogen","year":"2017","journal-title":"Academic Pediatrics"},{"issue":"12\u201314","key":"10.1016\/j.josat.2023.209030_bb0035","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3109\/10826080009148241","article-title":"Development of a \u201ctreatment program\u201d descriptor: The Addiction Treatment Inventory","volume":"35","author":"Carise","year":"2000","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2023.209030_bb0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jsat.2019.04.010","article-title":"A statewide quality improvement (QI) initiative for better health outcomes and family stability among pregnant women with opioid use disorder (OUD) and their infants","volume":"102","author":"Crane","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2023.209030_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsat.2006.06.016","article-title":"The role of organization and management in substance abuse treatment: Review and roadmap","volume":"31","author":"D'Aunno","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1016\/j.josat.2023.209030_bb0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/jp.2008.70","article-title":"Substance abuse treatment linked with prenatal visits improves perinatal outcomes: A new standard","volume":"28","author":"Goler","year":"2008","journal-title":"Journal of Perinatology"},{"issue":"1","key":"10.1016\/j.josat.2023.209030_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2021.100489","article-title":"Integrated vs nonintegrated treatment for perinatal opioid use disorder: Retrospective cohort study","volume":"4","author":"Goodman","year":"2022","journal-title":"American Journal of Obstetrics & Gynecology MFM"},{"issue":"1","key":"10.1016\/j.josat.2023.209030_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.05.012","article-title":"Substance abuse treatment entry, retention, and outcome in women: A review of the literature","volume":"86","author":"Greenfield","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"31","key":"10.1016\/j.josat.2023.209030_bb0065","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999\u20132014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"3","key":"10.1016\/j.josat.2023.209030_bb0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","volume":"40","author":"Hansen","year":"2013","journal-title":"The Journal of Behavioral Health Services & Research"},{"issue":"May 9, 2012","key":"10.1016\/j.josat.2023.209030_bb0075","first-page":"1974","article-title":"Epidemic of prescription opiate abuse and neonatal abstinence","volume":"307","author":"Hayes","year":"2012","journal-title":"JAMA: Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/j.josat.2023.209030_bb0080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11414-020-09706-4","article-title":"Organizational facilitators and barriers to medication for opioid use disorder capacity expansion and use","volume":"47","author":"Jacobson","year":"2020","journal-title":"The Journal of Behavioral Health Services & Research"},{"issue":"3","key":"10.1016\/j.josat.2023.209030_bb0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.semperi.2019.01.002","article-title":"Models of care for opioid dependent pregnant women","volume":"43","author":"Johnson","year":"2019","journal-title":"Seminars in Perinatology"},{"issue":"5","key":"10.1016\/j.josat.2023.209030_bb0090","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/10550490802266276","article-title":"Methadone maintenance vs. methadone taper during pregnancy: Maternal and neonatal outcomes","volume":"17","author":"Jones","year":"2008","journal-title":"The American Journal on Addictions"},{"issue":"Supplement 1","key":"10.1016\/j.josat.2023.209030_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: A comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2023.209030_bb0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsat.2006.06.018","article-title":"The business of addiction treatment: A research agenda","volume":"31","author":"Kimberly","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1016\/j.josat.2023.209030_bb0105","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1177\/1049732318765720","article-title":"Rural postpartum women with substance use disorders","volume":"28","author":"Kramlich","year":"2018","journal-title":"Qualitative Health Research"},{"issue":"5","key":"10.1016\/j.josat.2023.209030_bb0110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder","volume":"133","author":"Krans","year":"2019","journal-title":"Obstetrics & Gynecology"},{"issue":"9","key":"10.1016\/j.josat.2023.209030_bb0115","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment","volume":"76","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2023.209030_bb0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jsat.2004.03.003","article-title":"A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an addiction treatment system","volume":"26","author":"McGovern","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2023.209030_bb0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0740-5472(03)00156-9","article-title":"Can the national addiction treatment infrastructure support the public's demand for quality care?","volume":"25","author":"McLellan","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.josat.2023.209030_bb0130","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2105\/AJPH.2016.303473","article-title":"Deaths from unintentional injury, homicide, and suicide during or within 1 year of pregnancy in Philadelphia","volume":"106","author":"Mehta","year":"2016","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2023.209030_bb0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ypmed.2015.07.015","article-title":"Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas","volume":"80","author":"Meyer","year":"2015","journal-title":"Preventive Medicine"},{"issue":"Mar 2017","key":"10.1016\/j.josat.2023.209030_bb0140","article-title":"A public health response to opioid use in pregnancy","volume":"139","author":"Patrick","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.josat.2023.209030_bb0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5195\/jmla.2018.319","article-title":"Research electronic data capture (REDCap)","volume":"106","author":"Patridge","year":"2018","journal-title":"Journal of the Medical Library Association"},{"issue":"5","key":"10.1016\/j.josat.2023.209030_bb0150","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/AOG.0000000000003503","article-title":"Methadone, buprenorphine, or detoxification for management of perinatal opioid use disorder: A cost-effectiveness analysis","volume":"134","author":"Premkumar","year":"2019","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1016\/j.josat.2023.209030_bb0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","volume":"130","author":"Reddy","year":"2017","journal-title":"Obstetrics & Gynecology"},{"issue":"4","key":"10.1016\/j.josat.2023.209030_bb0160","first-page":"212","article-title":"Care and treatment recommendations for pregnant women with opioid use disorder","volume":"44","author":"Reising","year":"2019","journal-title":"MCN: The American journal of Maternal\/ChildNursing"},{"issue":"2","key":"10.1016\/j.josat.2023.209030_bb0165","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1016\/j.josat.2023.209030_bb0170","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5734","article-title":"Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts","volume":"3","author":"Schiff","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.209030_bb0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsat.2018.04.003","article-title":"Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States","volume":"89","author":"Short","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.josat.2023.209030_bb0180","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/AOG.0000000000003279","article-title":"Pregnancy-associated death in Utah: Contribution of drug-induced deaths","volume":"133","author":"Smid","year":"2019","journal-title":"Obstetrics & Gynecology"},{"issue":"4","key":"10.1016\/j.josat.2023.209030_bb0185","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/AOG.0000000000003988","article-title":"Standardized criteria for review of perinatal suicides and accidental drug-related deaths","volume":"136","author":"Smid","year":"2020","journal-title":"Obstetrics & Gynecology"},{"key":"10.1016\/j.josat.2023.209030_bb0205","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40263-015-0273-8","article-title":"Pharmacological management of opioid use disorder in pregnant women","volume":"29","author":"Wilder","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.josat.2023.209030_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.106014","article-title":"Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations","volume":"93","author":"Winhusen","year":"2020","journal-title":"Contemporary Clinical Trials"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:52Z","timestamp":1762652392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923000802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":38,"alternative-id":["S2949875923000802"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209030","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209030"}}